Cargando…

Description of the COVID 2.0 survey in the NAKO and first results

INTRODUCTION: The COVID-19 pandemic had a huge impact on society and raised attention to the challenges related to infectious diseases. While a lot of research was initiated during the pandemic, the recruitment of participants in most instances started at the time point of infection. In contrast, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikolajczyk, R, Diexer, S, Fricke, J, Ahnert, P, Pischon, T, Karch, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596589/
http://dx.doi.org/10.1093/eurpub/ckad160.502
_version_ 1785125140277755904
author Mikolajczyk, R
Diexer, S
Fricke, J
Ahnert, P
Pischon, T
Karch, A
author_facet Mikolajczyk, R
Diexer, S
Fricke, J
Ahnert, P
Pischon, T
Karch, A
author_sort Mikolajczyk, R
collection PubMed
description INTRODUCTION: The COVID-19 pandemic had a huge impact on society and raised attention to the challenges related to infectious diseases. While a lot of research was initiated during the pandemic, the recruitment of participants in most instances started at the time point of infection. In contrast, the German National Cohort (NAKO Gesundheitsstudie) has the ability to study pre-existing risk factors. In order to obtain information about SARS-CoV-2 infections and the following sequelae a dedicated data collection was conducted. METHODS: An online survey was conducted in the NAKO between September 2022 and February 2023. Invitation via e-mail was followed by two reminders sent to all NAKO study participants who provided e-mail addresses. The questionnaire was implemented in LimeSurvey and included the following topics: current health status including mental health measurements, restrictions of health services during the pandemic, other collateral effects of the pandemic, reported infections with SARS-CoV-2 and symptoms of acute infection, 4-12 weeks, 12 or more weeks, and one year after infection as well as vaccination status. RESULTS: Of 150766 invited NAKO participants, 110362 responded to the second COVID-19 questionnaire. Respondents in 60% reported at least one SARS-CoV-2 infection, 59453 reported one, 6061 two, and 414 three or more infections. The time points of infections followed the general incidence in the German population and thus infections could be mapped to specific variants based on periods of dominance. Of those who reported an infection with SARS-CoV-2, 42% reported symptoms 4 to 12 weeks after infection (ongoing COVID-19), 35% reported symptoms 12 or more weeks after infection (Post-COVID-19), and 37% one year after infection. CONCLUSIONS: Combined with existing biosamples and measurements prior to infection, NAKO offers an excellent opportunity to study risk factors for infection and post-infection syndromes.
format Online
Article
Text
id pubmed-10596589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105965892023-10-25 Description of the COVID 2.0 survey in the NAKO and first results Mikolajczyk, R Diexer, S Fricke, J Ahnert, P Pischon, T Karch, A Eur J Public Health Parallel Programme INTRODUCTION: The COVID-19 pandemic had a huge impact on society and raised attention to the challenges related to infectious diseases. While a lot of research was initiated during the pandemic, the recruitment of participants in most instances started at the time point of infection. In contrast, the German National Cohort (NAKO Gesundheitsstudie) has the ability to study pre-existing risk factors. In order to obtain information about SARS-CoV-2 infections and the following sequelae a dedicated data collection was conducted. METHODS: An online survey was conducted in the NAKO between September 2022 and February 2023. Invitation via e-mail was followed by two reminders sent to all NAKO study participants who provided e-mail addresses. The questionnaire was implemented in LimeSurvey and included the following topics: current health status including mental health measurements, restrictions of health services during the pandemic, other collateral effects of the pandemic, reported infections with SARS-CoV-2 and symptoms of acute infection, 4-12 weeks, 12 or more weeks, and one year after infection as well as vaccination status. RESULTS: Of 150766 invited NAKO participants, 110362 responded to the second COVID-19 questionnaire. Respondents in 60% reported at least one SARS-CoV-2 infection, 59453 reported one, 6061 two, and 414 three or more infections. The time points of infections followed the general incidence in the German population and thus infections could be mapped to specific variants based on periods of dominance. Of those who reported an infection with SARS-CoV-2, 42% reported symptoms 4 to 12 weeks after infection (ongoing COVID-19), 35% reported symptoms 12 or more weeks after infection (Post-COVID-19), and 37% one year after infection. CONCLUSIONS: Combined with existing biosamples and measurements prior to infection, NAKO offers an excellent opportunity to study risk factors for infection and post-infection syndromes. Oxford University Press 2023-10-24 /pmc/articles/PMC10596589/ http://dx.doi.org/10.1093/eurpub/ckad160.502 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Mikolajczyk, R
Diexer, S
Fricke, J
Ahnert, P
Pischon, T
Karch, A
Description of the COVID 2.0 survey in the NAKO and first results
title Description of the COVID 2.0 survey in the NAKO and first results
title_full Description of the COVID 2.0 survey in the NAKO and first results
title_fullStr Description of the COVID 2.0 survey in the NAKO and first results
title_full_unstemmed Description of the COVID 2.0 survey in the NAKO and first results
title_short Description of the COVID 2.0 survey in the NAKO and first results
title_sort description of the covid 2.0 survey in the nako and first results
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596589/
http://dx.doi.org/10.1093/eurpub/ckad160.502
work_keys_str_mv AT mikolajczykr descriptionofthecovid20surveyinthenakoandfirstresults
AT diexers descriptionofthecovid20surveyinthenakoandfirstresults
AT frickej descriptionofthecovid20surveyinthenakoandfirstresults
AT ahnertp descriptionofthecovid20surveyinthenakoandfirstresults
AT pischont descriptionofthecovid20surveyinthenakoandfirstresults
AT karcha descriptionofthecovid20surveyinthenakoandfirstresults